Home » News Room
Pharmaceutical News

News

News at Salix

Search

May 18, 2012
Salix Pharmaceuticals Outlines Data Presentations At Digestive Disease Week 2012

May 07, 2012
Salix Pharmaceuticals Reports 1Q2012 Results

May 01, 2012
Salix Pharmaceuticals To Present At Three Investment Conferences In May

April 30, 2012
Salix Pharmaceuticals Announces Extension Of Crofelemer NDA Priority Review

April 25, 2012
Salix And Progenics Announce FDA Extension Of Relistor® sNDA Goal Date To July 27, 2012

April 23, 2012
Salix Pharmaceuticals Announces 1Q2012 Financial Results Conference Call And Webcast

March 16, 2012
Salix Pharmaceuticals Closes Sale Of Convertible Notes

March 13, 2012
Salix Pharmaceuticals Prices Convertible Notes Offering

March 12, 2012
Salix Pharmaceuticals Announces Proposed Convertible Notes Offering

February 28, 2012
Salix Pharmaceuticals To Present At Cowen Health Care Conference

February 27, 2012
Salix Pharmaceuticals Reports 4Q and FY2011 Results

February 21, 2012
Salix Pharmaceuticals Announces Initiation Of Target 3: A Phase 3 Study To Assess Repeat Treatment Efficacy And Safety Of Rifaximin 550Mg TID In Subjects With Irritable Bowel Syndrome With Diarrhea

February 21, 2012
Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

February 13, 2012
Salix Pharmaceuticals Announces 4Q2011 and FY2011 Financial Results Conference Call and Webcast

February 07, 2012
Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation for the Crofelemer NDA for Treatment of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy

January 04, 2012
Salix Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

December 20, 2011
Salix Pharmaceuticals Completes Acquisition of Oceana Therapeutics

December 20, 2011
Salix and Progenics Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation

December 14, 2011
Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea

November 29, 2011
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference

November 16, 2011
FDA Advisory Committee Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with Diarrhea

November 08, 2011
Salix Pharmaceuticals to Acquire Oceana Therapeutics

November 08, 2011
Salix Pharmaceuticals Reports 3Q2011 Results and Raises 2011 Guidance

November 04, 2011
Salix Pharmaceuticals Previews Data Slated for Presentation at 62nd Annual Meeting of The American Association for The Study of Liver Diseases

November 03, 2011
Salix Pharmaceuticals to Present at Two Investment Conferences in November

Thank you for signing up. You will recieve a confirmation e-mail shortly./p>

Salix Pharmaceuticals on Facebook   Salix Pharmaceuticals on Twitter